SCHEMBL25979229

SCHEMBL25979229

c1ccc(-c2ccc(N(c3ccccc3)c3ccccc3-c3ccc4oc5cc(-c6nc(-c7ccccc7)nc(-c7ccccc7)n6)ccc5c4c3)cc2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP12 P39900 2/20 0.33
▸ PIM1 P11309 1/20 0.33
▸ CSNK2A2 P19784 1/20 0.33
▸ CSNK2B P67870 1/20 0.33
▸ PIM3 Q86V86 1/20 0.33
▸ PIM2 Q9P1W9 1/20 0.33
▸ PLA2G2A P14555 2/20 0.31
▸ PLA2G4A P47712 2/20 0.31
▸ GAA P10253 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ CHEK2 O96017 1/20 0.31
▸ MAPT P10636 3/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ HPGD P15428 2/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ NR1H4 Q96RI1 1/20 0.30
▸ MMP13 P45452 1/20 0.30
▸ HSP90AA1 P07900 1/20 0.30
▸ HSP90AB1 P08238 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25978972 0.97 PIM1 (0.34) MMP12PIM1CSNK2A2CSNK2BPIM3
SCHEMBL25979780 0.95 MEN1 (0.33) MMP12GAAL3MBTL1MAPTALDH1A1
SCHEMBL25978705 0.93 MMP12 (0.32) MMP12MAPTALDH1A1HPGDMEN1
SCHEMBL25978748 0.93 MMP12 (0.32) MMP12PIM1CSNK2A2CSNK2BPIM3
SCHEMBL25979781 0.93 KMT2A (0.35) L3MBTL1MAPTALDH1A1HPGDMEN1
SCHEMBL26779237 0.92 MAPT (0.33) MMP12PIM1CSNK2A2CSNK2BPIM3
SCHEMBL25979481 0.90 MAPT (0.34) L3MBTL1MAPTALDH1A1HPGDMEN1
SCHEMBL25979497 0.90 MAPT (0.34) GAAL3MBTL1MAPTALDH1A1HPGD
SCHEMBL24609386 0.88 MMP12 (0.35) MMP12PLA2G2APLA2G4AMAPTALDH1A1
SCHEMBL24574978 0.88 PLA2G2A (0.38) MMP12PIM1CSNK2A2CSNK2BPIM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 — — US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 — — US disclosed
EP-4227301-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-08-16 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 MMP12 4355/4885PIM1 1100/4885CSNK2A2 1764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback